Eloxx Pharmaceuticals, Inc. — DEF 14A

Eloxx Pharmaceuticals, Inc. of ARLINGTON, MA filed a DEF 14A with the SEC on 2022-04-29. Industry: Biological Products, (No Diagnostic Substances).

Filing

Documents (22)

Showing 15 of 22 documents.

SeqTypeDescription
1DEF 14ADEF 14A
2GRAPHICedge20002463x1_alanewalts.jpg
3GRAPHICedge20002463x1_chairx1.jpg
4GRAPHICedge20002463x1_chairx2.jpg
5GRAPHICedge20002463x1_device.jpg
6GRAPHICedge20002463x1_gadiveinrib.jpg
7GRAPHICedge20002463x1_internet.jpg
8GRAPHICedge20002463x1_jasbirseehra.jpg
9GRAPHICedge20002463x1_mail.jpg
10GRAPHICedge20002463x1_meeting.jpg
11GRAPHICedge20002463x1_pc01.jpg
12GRAPHICedge20002463x1_pc02.jpg
13GRAPHICedge20002463x1_phone.jpg
14GRAPHICedge20002463x1_rajeshparckh.jpg
15GRAPHICedge20002463x1_rannussbatum.jpg

Filing timeline for this registrant (53)

Showing 12 of 53 filings.

FiledForm
2026-05-08DEF 14C
2026-04-28PRE 14C
2023-04-28DEFA14A
2023-04-28DEF 14A
2022-10-31DEF 14A
2022-10-17PRE 14A
2022-04-29DEFA14A
2022-04-29DEF 14A
2021-04-01DEFA14A
2021-04-01DEF 14A
2020-04-01DEFA14A
2020-04-01DEF 14A

More